Antineoplastic AgentsRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationDrug Screening Assays, AntitumorCell Line, TumorRadiation ProtectionRadiation MonitoringNeoplasmsDoxorubicinApoptosisDrug Resistance, NeoplasmCell SurvivalRadiation OncologyAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticDrug Delivery SystemsCosmic RadiationGamma RaysRadiation Injuries, ExperimentalTumor Cells, CulturedDNA DamageMolecular StructureDrug CarriersRadiation PneumonitisXenograft Model Antitumor AssaysMice, NudeNeoplasms, Radiation-InducedRadiation-Sensitizing AgentsRadiotherapyCell ProliferationEllipticinesBackground RadiationUltraviolet RaysDose-Response Relationship, DrugInhibitory Concentration 50EtoposideDrug DesignCamptothecinRadiometryPaclitaxelCombined Modality TherapyDrug Resistance, MultipleRadiotherapy DosageP-GlycoproteinRadiation EffectsCell CycleDrug SynergismTime FactorsDrug Evaluation, PreclinicalBreast NeoplasmsRadiation-Protective AgentsModels, ChemicalEnzyme InhibitorsPlant ExtractsProdrugsDNA Topoisomerases, Type IIDrug DiscoveryMagnetic Resonance SpectroscopyDNANanoparticlesStructure-Activity RelationshipDNA RepairNanomedicineGene Expression Regulation, NeoplasticFluorouracilTopoisomerase I InhibitorsAcute Radiation SyndromeModels, BiologicalDaunorubicinTumor Suppressor Protein p53Signal TransductionMolecular Sequence DataNeoplasms, ExperimentalPlatinumX-RaysModels, MolecularColonic NeoplasmsNanocapsulesCaspasesNeoplasm TransplantationAntimetabolites, AntineoplasticRadioactive Hazard ReleaseCobalt RadioisotopesCell DivisionCell LineAntineoplastic Combined Chemotherapy ProtocolsOrganoplatinum CompoundsRadiobiologyCaspase 3Radiotherapy, ConformalDNA AdductsProto-Oncogene Proteins c-bcl-2Cell DeathRadiation Hybrid MappingMolecular Targeted Therapy